CD44 and cancer: Extensive studies revealed that high CD44 expression correlates with a mesenchymal phenotype of cancer stem cells and participates in the EMT, resulting in tumors with worse prognosis showing highly invasive, metastatic, and chemo-radiation-resistant features [125,127].